The US administration has now taken the emergency decision to use synthetic antibody therapy given to US President Donald Trump in treating Covid-19. After this decision taken on Saturday, the coronavirus infection will be treated without the patient being admitted to the hospital.
American Food and Drug Administration Commissioner Stephen Han said, “Authorizing these monoclonal antibody therapies can help reduce hospitalization and burden on our healthcare.”
Let us tell you that due to this therapy, Donald Trump had defeated Coronavirus infection in a short time last month and returned to the election campaign. Two monoclonal antibodies REGN10933 and REGN10987 were used in this therapy that inactivates the SARS-COV-2 virus. This stops its body from spreading and reduces the reaction time.